# Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 Diabetes

> **NCT00562133** · PHASE3 · COMPLETED · sponsor: **IKFE Institute for Clinical Research and Development** · enrollment: 15 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Insulin Glulisine
- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT00562133
- **Lead sponsor:** IKFE Institute for Clinical Research and Development
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2007-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00562133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00562133, "Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00562133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*